Contact
    Start Publications Broad spectrum antiviral activity for paramyxoviruses is ...
    ←  Publication Finder
    Attension

    Broad spectrum antiviral activity for paramyxoviruses is modulated by biophysical properties of fusion inhibitory peptides

    Year: 2017

    Journal: Sci Rep, Volume 7, nov-08

    Authors: Mathieu, Cyrille; Augusto, Marcelo T.; Niewiesk, Stefan; Horvat, Branka; Palermo, Laura M.; Sanna, Giuseppina; Madeddu, Silvia; Huey, Devra; Castanho, Miguel A. R. B.; Porotto, Matteo; Santos, Nuno C.; Moscona, Anne

    Organizations: NIH [RO1AI114736, R33AI101333, RO1AI031971]; Fundacao para a Ciencia e Tecnologia-Ministerio da Educao e Ciencia (FCT-MEC, Portugal) [SFRH/BD/95624/2013]; Fundacao Luso Americana para o Desenvolvimento (FLAD) [4/2016]; [ANR-ASTRID-2011]

    Human paramyxoviruses include global causes of lower respiratory disease like the parainfluenza viruses, as well as agents of lethal encephalitis like Nipah virus. Infection is initiated by viral glycoprotein-mediated fusion between viral and host cell membranes. Paramyxovirus viral fusion proteins (F) insert into the target cell membrane, and form a transient intermediate that pulls the viral and cell membranes together as two heptad-repeat regions refold to form a six-helix bundle structure that can be specifically targeted by fusion-inhibitory peptides. Antiviral potency can be improved by sequence modification and lipid conjugation, and by adding linkers between the protein and lipid components. We exploit the uniquely broad spectrum antiviral activity of a parainfluenza F-derived peptide sequence that inhibits both parainfluenza and Nipah viruses, to investigate the influence of peptide orientation and intervening linker length on the peptides' interaction with transitional states of F, solubility, membrane insertion kinetics, and protease sensitivity. We assessed the impact of these features on biodistribution and antiviral efficacy in vitro and in vivo. The engineering approach based on biophysical parameters resulted in a peptide that is a highly effective inhibitor of both paramyxoviruses and a set of criteria to be used for engineering broad spectrum antivirals for emerging paramyxoviruses.
    View publication